comparemela.com

Latest Breaking News On - Cox 2 inhibitors - Page 1 : comparemela.com

COX–2 Inhibitors, Selective Non-Steroidal Anti-Inflammatory Drugs

What are COX–2 Inhibitors? Why are they safer compared to NSAIDs and which conditions are best treated by these drugs. Learn more about COX-2 inhibitors.

Rheumatoid-arthritis
Cox-2-inhibitors
Yclooxygenase-2-inhibitors
Pain-relievers
Elective-nsaids

Discovery of new compounds that synergistically interfere with COX-2 activity and tubulin polymerization

Researchers from Umm Al-Qura University and affiliated organizations have published details on the discovery and preclinical evaluation of anticancer candidates acting both as COX-2 inhibitors and tubulin-targeting agents.

Umm-al-qura-university
Cox-2-inhibitors
Tubulin-targeting-agents

Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: A nationwide cohort study

Eun-Young Choi and colleagues investigate whether early prenatal exposure to non-steroidal anti-inflammatory drugs was associated with adverse neonatal and maternal outcomes in South Korea.

United-states
United-kingdom
South-korea
Han
Korea
Jennifer-thorley
Daiichi-sankyo
International-classification-of-disease
Information-communication-technology
Ministry-of-health
Pfizer
National-research-foundation-of-south-korea

Unichem Labs gains ater USFDA approval for celecoxib capsules

Unichem Laboratories gained 1.15% to Rs 280.85 after the company said it received US drug regulator s approval for celecoxib capsules, an anti-inflammatory drug. In a regulatory filing made during market hours today, the company said that it had received ANDA approval for its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (US FDA). The product is a generic version of Celebrex capsules of G.D. Searle LLC, Division of Pfizer Inc. Celecoxib capsules are indicated for treatment of osteoarthritis, rheumatoid arthritis juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain and primary dysmenorrhea. The product will be commercialized from Unichem s Goa Plant, the company said in a statement.

United-states
Gd-searle
Drug-administration
Division-of-pfizer-inc
Unichem-laboratories
Celecoxib-capsules
United-states-food
Goa-plant
Capital-market
Non-steroidal-anti-inflammatory-drugs
Cox-2-inhibitors

Unichem Labs gets USFDA nod to market capsules to treat osteoarthritis

Drug firmUnichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic Celecoxib capsules used for treatment of osteoarthritis, rheumatoid arthritis and acute pain. The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United StatesFood and Drug Administration (USFDA),Unichem said in a filing to BSE. The capsules are generic versions of GD Searle LLC s Celebrexcapsules in the same strengths, it added. The product will be commercialized from the company s Goa plant, the filing said. Celecoxib capsules are indicated for treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain and primary dysmenorrhea, it added.

Drug-administration
Gd-searle
Unichem-laboratories
United-states-food
Medical-specialties
Clinical-medicine
Medicine
Rheumatology
Non-steroidal-anti-inflammatory-drugs
Cox-2-inhibitors
Skeletal-disorders

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.